Dimed Distribuidora de Medicamentos (BSP:PNVL3) E10: R$0.93 (As of Mar. 2026)


BSP:PNVL3 Dimed SA Distribuidora de Medicamentos BSP:PNVL3
88 GF Score
Price R$11.34
GF Value R$13.48
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dimed Distribuidora de Medicamentos E10?

Dimed Distribuidora de Medicamentos BSP:PNVL3 +0.35% 88 E10 is R$0.93 as of Mar. 2026. GuruFocus rates BSP:PNVL3 with a GF Score™ of 88/100 and a GF Value™ of R$13.48 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dimed Distribuidora de Medicamentos's adjusted earnings per share data for the three months ended in Mar. 2026 was R$0.220. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$0.93 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Dimed Distribuidora de Medicamentos's average E10 Growth Rate was 6.90% per year. During the past 3 years, the average E10 Growth Rate was 5.70% per year. During the past 5 years, the average E10 Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Dimed Distribuidora de Medicamentos was 5.70% per year. The lowest was 4.30% per year. And the median was 4.60% per year.

As of today (2026-06-29), Dimed Distribuidora de Medicamentos's current stock price is R$11.34. Dimed Distribuidora de Medicamentos's E10 for the quarter that ended in Mar. 2026 was R$0.93. Dimed Distribuidora de Medicamentos's Shiller PE Ratio of today is 12.19.

During the past 13 years, the highest Shiller PE Ratio of Dimed Distribuidora de Medicamentos was 32.51. The lowest was 9.40. And the median was 14.42.


Dimed Distribuidora de Medicamentos  (BSP:PNVL3) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dimed Distribuidora de Medicamentos's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=11.34/0.93
=12.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Dimed Distribuidora de Medicamentos was 32.51. The lowest was 9.40. And the median was 14.42.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dimed Distribuidora de Medicamentos E10 Related Terms


Dimed Distribuidora de Medicamentos E10 Historical Data

* Premium members only.

The historical data trend for Dimed Distribuidora de Medicamentos's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos E10 Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.77 0.80 0.84 0.91

Dimed Distribuidora de Medicamentos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.88 0.89 0.91 0.93

BSP:PNVL3 vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Shiller PE Ratio falls into.


BSP:PNVL3
88GF Score
Dimed SA Distribuidora de Medicamentos BSP:PNVL3
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimed Distribuidora de Medicamentos E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dimed Distribuidora de Medicamentos's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.22/175.0655*175.0655
=0.220

Current CPI (Mar. 2026) = 175.0655.

Dimed Distribuidora de Medicamentos Quarterly Data

per share eps CPI Adj_EPS
201606 0.091 108.851 0.146
201609 0.107 109.986 0.170
201612 0.112 110.802 0.177
201703 0.099 111.869 0.155
201706 0.109 112.115 0.170
201709 0.114 112.777 0.177
201712 0.112 114.068 0.172
201803 0.092 114.868 0.140
201806 0.114 117.038 0.171
201809 1.520 117.881 2.257
201812 0.186 118.340 0.275
201903 0.100 120.124 0.146
201906 0.130 120.977 0.188
201909 0.260 121.292 0.375
201912 0.160 123.436 0.227
202003 0.110 124.092 0.155
202006 0.020 123.557 0.028
202009 0.110 125.095 0.154
202012 0.130 129.012 0.176
202103 0.130 131.660 0.173
202106 0.140 133.871 0.183
202109 0.100 137.913 0.127
202112 0.150 141.992 0.185
202203 0.140 146.537 0.167
202206 0.160 149.784 0.187
202209 0.120 147.800 0.142
202212 0.160 150.207 0.186
202303 0.120 153.352 0.137
202306 0.150 154.519 0.170
202309 0.160 155.464 0.180
202312 0.190 157.148 0.212
202403 0.230 159.372 0.253
202406 0.030 161.052 0.033
202409 0.240 162.342 0.259
202412 0.208 164.740 0.221
202503 0.170 168.102 0.177
202506 0.170 169.670 0.175
202509 0.210 170.739 0.215
202512 0.280 171.765 0.285
202603 0.220 175.066 0.220

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$0.93 mean?
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a E10 of R$0.93 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dimed Distribuidora de Medicamentos and its competitors.
Is Dimed Distribuidora de Medicamentos' E10 too high?
Dimed Distribuidora de Medicamentos' current E10 is R$0.93. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' E10 compare to LLY and JNJ?
Dimed Distribuidora de Medicamentos' E10 of R$0.93 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dimed Distribuidora de Medicamentos and its competitors. Dimed Distribuidora de Medicamentos's current E10 is R$0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.48, compared to a current price of R$11.34 — trading 15.9% below its estimated fair value. The current E10 is R$0.93. Dimed Distribuidora de Medicamentos' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current E10 is R$0.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?

Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued. The current stock price of R$11.34 is trading 15.9% below its estimated GF Value™ of R$13.48. GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.

Key valuation signals for BSP:PNVL3:

  • E10: R$0.93
  • GF Value™: R$13.48 vs. price of R$11.34 (15.9% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dimed Distribuidora de Medicamentos Business Description

Address Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
88GF Score

Get the complete analysis for BSP:PNVL3

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$11.34
Price
R$13.48
GF Value